Lv7
3360 积分 2024-07-26 加入
Delivering on the promise of protein degraders
18天前
已完结
Molecular glue degraders: exciting opportunities for novel drug discovery
18天前
已完结
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
20天前
已完结
MYC in cancer: from undruggable target to clinical trials
26天前
已完结
Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)–MYC Interaction
26天前
已完结
Rational Design and Systemic Appraisal of an EGFR-Targeting Antibody–Drug Conjugate LR-DM1 for Pancreatic Cancer
1个月前
已完结
Antibody drug conjugates beyond cytotoxic payloads
1个月前
已完结
The medicinal chemistry evolution of antibody–drug conjugates
1个月前
已完结
Discovery of ABBV-154, an anti-TNF Glucocorticoid Receptor Modulator Immunology Antibody-Drug Conjugate (iADC)
1个月前
已完结
Engineered exosomes: a transformative therapeutic modality
1个月前
已完结
皖公网安备34019202002308
